Biosimulation Market 2025 Growth Trends, Share - Global Analysis and Forecasts

Biosimulation Market to 2025 - Global Analysis and Forecasts by Product (Software and Services), Application (Drug Discovery, Drug Development and Others); and By End User (Pharmaceutical & Biotechnology Companies, Academic Research Institutions and Others)

Report Code: TIPHE100001203 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Biosimulation is a mathematical simulation of biological process in which computer aided programs are used for the simulation of biological processes and systems. It is also known as model-based drug development that has ability to make data-driven decisions at all stages of drug development through a quantitative framework. Biosimulation is a promising technology that especially used in pharmaceutical research to improve the drug discovery and development cycle of a drug.

The growth of the biosimulation technology can be attributed to the increasing focuses on advanced drugs development. Additionally, the increasing healthcare spending and improved simulation techniques are also helps to upsurge the growth of the market. Moreover, the increased accuracy of prediction before an actual trial and increasing healthcare expenditure along with technological advancements are likely to add novel opportunities for the global biosimulation market in the forecast period.

The "Global Biosimulation Market Analysis to 2025" is a specialized and in-depth study of the healthcare industry with a focused global market trend. The report aims to provide an overview of global biosimulation market with detailed market segmentation by product, application, end user, and geography. The global biosimulation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

On the basis of product the market is segmented into software and services. The application market is segmented into drug discovery, drug development and others. Based on the end user, the market is classified as pharmaceutical & biotechnology companies, academic research institutions and others.
The report provides a detailed overview on the industry overview and forecast of the global biosimulation based on product, application and end user. It also provides market size and forecast till 2025 for overall Biosimulation market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America followed by Europe, is expected to dominate the biosimulation market in the global arena due to the increasing growth in pharmaceutical and biotechnology industry and the growing adoption of biosimulation software by regulatory bodies in the region. The Asia-Pacific region anticipated to show a significant growth rate due to the increasing demand for advanced computer technologies in the biosimulation market over the next five years.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key Biosimulation manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Simulations Plus, Certara USA, Inc., Schrödinger, LLC, Dassault Systèmes, Rosa & Co., LLC, Genedata AG, DASSAULT SYSTÈMES, Leadscope, Inc., Evidera, Advanced Chemistry Development and others.






1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance

2 Key Takeaways

3 Biosimulation Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Biosimulation Market - By Product
3.2.2 Biosimulation Market - By Application
3.2.3 Biosimulation Market - By End User
3.2.4 Biosimulation Market - By Region
3.2.4.1 By Country
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America - PEST Analysis

4 Biosimulation Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis

5 Biosimulation Market - Global Analysis
5.1 Global Biosimulation Market Overview
5.2 Global Biosimulation Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Expert Opinions
6 Biosimulation Market Revenue and Forecasts to 2025 - Product (US$ Mn)
6.1 Overview
6.2 Product Market Revenue Forecasts and Analysis
6.3 Software Market
6.3.1 Overview
6.3.2 Software Market Revenue Forecasts and Analysis (US$ Mn)
6.4 Services Market
6.4.1 Overview
6.4.2 Services Market Revenue Forecasts and Analysis (US$ Mn)

7 Biosimulation Market Revenue and Forecasts to 2025 - Application (US$ Mn)
7.1 Overview
7.2 Application Market Revenue Forecasts and Analysis
7.3 Drug Discovery Market
7.3.1 Overview
7.3.2 Drug Discovery Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Drug Development Market
7.4.1 Overview
7.4.2 Drug Development Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Others Application Market
7.5.1 Overview
7.5.2 Others Application Market Revenue Forecasts and Analysis (US$ Mn)

8 Biosimulation Market Revenue and Forecasts to 2025 - End User (US$ Mn)
8.1 Overview
8.2 End User Market Revenue Forecasts and Analysis
8.3 Pharmaceutical & Biotechnology Companies Market
8.3.1 Overview
8.3.2 Pharmaceutical & Biotechnology Companies Market Revenue Forecasts and Analysis (US$ Mn)
8.4 Academic Research Institutions Market
8.4.1 Overview
8.4.2 Academic Research Institutions Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Other End Users Market
8.5.1 Overview
8.5.2 Other End Users Market Revenue Forecasts and Analysis (US$ Mn)

9 North America Biosimulation Market Revenue and Forecasts to 2025 - Country Analysis
9.1 North America Biosimulation Market Overview
9.2 North America Biosimulation Market Revenue Forecasts and Analysis (US$ Mn)
9.3 North America Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.4 North America Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.5 North America Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.6 North America Market Revenue Forecasts and Analysis - By Country
9.7 US Market Overview
9.7.1 US Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
9.7.2 US Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
9.7.3 US Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)
9.8 Canada Market Overview
9.8.1 Canada Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
9.8.2 Canada Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
9.8.3 Canada Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)
9.9 Mexico Market Overview
9.9.1 Mexico Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
9.9.2 Mexico Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
9.9.3 Mexico Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)

10 Europe Biosimulation Market Revenue and Forecasts to 2025 - Country Analysis
10.1 Europe Biosimulation Market Overview
10.2 Europe Biosimulation Market Revenue Forecasts and Analysis (US$ Mn)
10.3 Europe Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.4 Europe Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.5 Europe Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.6 Europe Market Revenue Forecasts and Analysis - By Country
10.7 UK Market Overview
10.7.1 UK Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.7.2 UK Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.7.3 UK Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)
10.8 Germany Market Overview
10.8.1 Germany Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.8.2 Germany Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.8.3 Germany Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)
10.9 France Market Overview
10.9.1 France Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.9.2 France Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.9.3 France Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)

11 Asia Pacific Biosimulation Market Revenue and Forecasts to 2025 - Country Analysis
11.1 Asia Pacific Biosimulation Market Overview
11.2 Asia Pacific Biosimulation Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Asia Pacific Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.4 Asia Pacific Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.5 Asia Pacific Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.6 Asia Pacific Market Revenue Forecasts and Analysis - By Country
11.7 Japan Market Overview
11.7.1 Japan Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.7.2 Japan Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.7.3 Japan Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.8 China Market Overview
11.8.1 China Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.8.2 China Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.8.3 China Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.9 India Market Overview
11.9.1 India Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.9.2 India Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.9.3 India Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)

12 Middle East and Africa (MEA) Biosimulation Market Revenue and Forecasts to 2025 - Geographical Analysis
12.1 Middle East & Africa (MEA) Biosimulation Market Overview
12.2 Middle East & Africa (MEA) Biosimulation Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Middle East & Africa (MEA) Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.4 Middle East & Africa (MEA) Market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.5 Middle East & Africa (MEA) Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.6 Middle East & Africa (MEA) Market Revenue Forecasts and Analysis - By Country
12.7 South Africa Market Overview
12.7.1 South Africa Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.7.2 South Africa Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.7.3 South Africa Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12.8 Saudi Arabia Market Overview
12.8.1 Saudi Arabia Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.8.2 Saudi Arabia Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.8.3 Saudi Arabia Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12.9 UAE Market Overview
12.9.1 UAE Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.9.2 UAE Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.9.3 UAE Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)

13 South and Central America Biosimulation Market Revenue and Forecasts to 2025 - Geographical Analysis
13.1 South and Central America Biosimulation Market Overview
13.2 South and Central America Biosimulation Market Revenue Forecasts and Analysis (US$ Mn)
13.3 South and Central America Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.4 South and Central America Market Revenue Forecasts and Analysis - By Application (US$ Mn)
13.5 South and Central America Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.6 South and Central America Market Revenue Forecasts and Analysis - By Country
13.7 Brazil Market Overview
13.7.1 Brazil Biosimulation Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.7.2 Brazil Biosimulation Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.7.3 Brazil Biosimulation Market Revenue Forecasts and Analysis-By End User (US$ Mn)

14 Industry Landscape
14.1 Organic Growth Strategies
14.1.1 New Product Launches
14.1.2 Marketing & Promotional Activities
14.2 Inorganic Growth Strategies
14.2.1 Partnerships, Collaborations, and Joint Ventures
14.2.2 Mergers & Acquisitions

15 Biosimulation Market, Key Company Profiles
15.1 Simulations Plus
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Financial Overview
15.1.4 Product Portfolio
15.1.5 Product Pipeline
15.1.6 SWOT Analysis
15.1.7 Key Developments
15.2 Certara USA, Inc.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Financial Overview
15.2.4 Product Portfolio
15.2.5 Product Pipeline
15.2.6 SWOT Analysis
15.2.7 Key Developments
15.3 Schrödinger, LLC
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Financial Overview
15.3.4 Product Portfolio
15.3.5 Product Pipeline
15.3.6 SWOT Analysis
15.3.7 Key Developments

15.4 Dassault Systèmes
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Overview
15.4.4 Product Portfolio
15.4.5 Product Pipeline
15.4.6 SWOT Analysis
15.4.7 Key Developments
15.5 Rosa & Co., LLC.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Financial Overview
15.5.4 Product Portfolio
15.5.5 Product Pipeline
15.5.6 SWOT Analysis
15.5.7 Key Developments
15.6 Genedata AG
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Financial Overview
15.6.4 Product Portfolio
15.6.5 Product Pipeline
15.6.6 SWOT Analysis
15.6.7 Key Developments
15.7 DASSAULT SYSTÈMES
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Financial Overview
15.7.4 Product Portfolio
15.7.5 Product Pipeline
15.7.6 SWOT Analysis
15.7.7 Key Developments
15.8 Leadscope, Inc.
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Financial Overview
15.8.4 Product Portfolio
15.8.5 Product Pipeline
15.8.6 SWOT Analysis
15.8.7 Key Developments
15.9 Evidera
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Financial Overview
15.9.4 Product Portfolio
15.9.5 Product Pipeline
15.9.6 SWOT Analysis
15.9.7 Key Developments
15.10 Advanced Chemistry Development
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Financial Overview
15.10.4 Product Portfolio
15.10.5 Product Pipeline
15.10.6 SWOT Analysis
15.10.7 Key Developments

16 Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
16.3 Research Methodology

The List of Companies

1. Simulations Plus
2. Certara USA, Inc.
3. Schrödinger, LLC
4. Dassault Systèmes
5. Rosa & Co., LLC
6. Genedata AG
7. DASSAULT SYSTÈMES
8. Leadscope, Inc.
9. Evidera
10. Advanced Chemistry Development

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book